Published December 27, 2012 | Version v1
Patent Open

ANTIBODY-LIGHT FUSION PRODUCTS FOR CANCER THERAPEUTICS

  • 1. University of Chicago

Contributors

Description

Antibody-LIGHT fusion products or conjugates stimulate immunity against tumors and eradicate metastases. Tumor-specific antibodies coupled with LIGHT effectively target metastatic tumors and reduces cancer metastases.

Files

US20120328558.pdf

Files (1.1 MB)

Name Size Download all
md5:4d26d90aecfcab3575e69e7e17648109
1.1 MB Preview Download

Additional details

Identifiers

Patent number
US 201213563372 A
Patent application number
US 2012/0328558 A1
Other
oai:uchicago.tind.io:7889

Dates

Patent filed
2012-07-31

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Pathology